Health Medical Pharma

J&J to file USFDA request to start trials for surgical robots

Johnson & Johnson will apply with the USFDA to start clinical trials in the second half of 2024 for its robotic surgical system.

Read More
Drugs Health Pharma

Abcam shareholders approve Danaher Corp acquisition for $5.7 billion

HQ Team November 7, 2023: Shareholders of Abcam Plc., a UK-based manufacturer and supplier of antibodies and reagents used for medical research, have.

Read More
Drugs Health Pharma

Opinion: Smoking, hypertension, stress snuffing out young people’s lives

By Dr K. Leelamoni November 7, 2023: My cousin’s son, 46, went to a hospital in the southern Indian state of Kerala as.

Read More
Drugs Health Pharma

US regulator may ban brominated vegetable oil in food products

HQ Team November 6, 2023: The USFDA plans to revoke a regulation authorising the use of brominated vegetable oil in food as it.

Read More
Climate Health Pharma

Air, freshwater, soil becoming saltier, posing an ‘existential threat’

HQ Team November 6, 2023: Human activities are making the earth’s air, freshwater and soil saltier, posing an “existential threat” if the trend.

Read More
Drugs Health Pharma

One in seven people in US reports having long Covid by the end of 2022

HQ Team November 6, 2023: One in seven people in the US has had long Covid by the end of 2022, according to.

Read More
Drugs Health Pharma

Zoliflodacin shows potential in treating drug-resistant super gonorrhea

HQ Team November 4, 2023: Scientists have discovered a possible treatment for antibiotic-resistant super gonorrhea. In a large experiment involving nearly a 1000.

Read More
Drugs Health Medical Pharma

Study finds insulin can be stored at room temp without losing potency

HQ team November 3, 2023: Recent research by Cochrane has found that insulin can maintain its efficacy for extended periods at room temperature..

Read More
Drugs Health Pharma

GSK to pay $1 billion to acquire exclusive rights for J&J hepatitis B therapy

 HQ Team November 1, 2023: GSK, a British pharmaceutical company, will pay $1 billion to Johnson & Johnson for transferring exclusive global rights.

Read More
Drugs Health Pharma

AstraZeneca inks $245 million deal with Cellectis for rare diseases

HQ Team November 1, 2023: AstraZeneca signed a $245 million deal with a French clinical-stage biotechnology firm, Cellectis, to speed up therapeutics in.

Read More